Stem cell and regenerative medicine: commercial and pharmaceutical implications - Artificial Cells, Cell Engineering and Therapy - page 452

22. Medicines in Development for Heart Disease and Stroke, Survey; PhRMA,
America's Pharmaceutical Companies, 2005.
23. Carod-Artal FJ et al., `Chagasic cardiomyopathy is independently associated with
ischemic stroke in Chagas disease'. Stroke, 2005, 36: 965.
24. Henning RJ, Abu-Ali H, Balis JU, Morgan MB, Willing AE, Sanberg PR, `Human
umbilical cord blood mononuclear cells for the treatment of acute myocardial
infarction'. Cell Transplant., 2004, 13(7±8): 729±739.
25. Wendel S, Brener Z, Camargo ME, Rassi A, `Chagas disease ± American
trypanosomiasis: its impact on transfusion and clinical medicine'. ISBT, SÄo Paulo,
Brazil, 2002.
26. Soares MBP et al., `Transplanted bone marrow cells repair heart tissue and reduce
myocarditis in chronic Chagasic mice'; Am. J. Pathol., 2004, 164: 441±447.
27. Vilas-Boas F, Feitosa GS, Soares MBP, Pinho Filho JA, Almeida A, Mota A, Carvalho
HG, Oliveira ADD, Ribeiro-dos-Santos R, `Bone marrow cell transplantation to the
myocardium of a patient with heart failure due to Chagas cardiomyopathy. A case
report'. Arquivos Brasileiros de Cardiologia, 2004, 82(2): 185±187.
28. Simon P, Hoerstrup MD, `Tissue engineering of functional trileaflet heart valves
from human marrow stromal cells'. Circulation, 2002, 106: I-143.
29. Beltrami AP et al., `Evidence that cardiac myocytes divide after myocardial
infarction'. New England J. Med., 2001, 344: 1750±1757.
30. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R,
Nadal-Ginard B, Bodine DM, Leri A, Anversa P, `Bone marrow cells regenerate
infarcted myocardium'. Nature; 2001, 410: 701±705.
31. Sanberg PR, Willing AE, Garbuzova-Davis S, Saporta S, Liu G, Sanberg CD,
Bickford PC, Klasko SK, El-Badri NS, `Umbilical cord blood-derived stem cells and
brain repair'. Ann NY Acad Sci., 2005, 1049: 67±83.
32. http://www.silvestrelabs.com.br/extragraftxg13
33. American Heart Association, http://www.strokecenter.org/prof/awards.htm
34. Lindvall O, Kokaia Z, `Recovery and rehabilitation in stroke: stem cells', Stroke,
2004, 35: 2691±2694.
35. http://www.duluthsuperior.com/mld/duluthsuperior/13074930.htm, Posted on 3
Nov. 2005, Gov. Jim Doyle: http://www.wisgov.state.wi.us/
36. Ahsan T, Nerem RM, `Bioengineered tissues: the science, the technology, and the
industry'. Orthod. Craniofacial Res., 2005, 8: 134±140.
37. Lei M, Podell ER, Baumann P, Cech TR, `DNA self-recognition in the structure of
Pot1 bound to telomeric single-stranded DNA'. Nature; 2003, 426: 198.
38. Shirasugi N, Adams AB, Durham MM, Lukacher AE, Xu H, Rees P et al.,
`Prevention of chronic rejection in murine cardiac allografts: a comparison of
chimerism and nonchimerism-inducing costimulation blockade-based tolerance
induction regimens'. J. Immunol., 2002, 169: 2677±2684.
39. Knudtzon S, `In vitro growth of granulocyte colonies from circulating cells in human
cord blood'. Blood, 1974, 43: 357±361.
40. Broxmeyer HE, Douglas GW, Hangoc G et al., `Human umbilical cord blood as a
potential source of transplantable hematopoietic stem/progenitor cells'. Proc. Natl.
Acad. Sci. USA, 1989, 86: 3828±3832.
41. Gallacher L et al., `Isolation and characterization of human CD34 ± Lin ± and
CD34 + Lin ± hematopoietic stem cells using cell surface markers AC133 and CD7'.
Blood, 2000, 95: 2813±2820.
42. Meagher RC, `Human umbilical cord blood cells: how useful are they for the
clinician?'. J. Hematotherapy Stem Cell Res., 2002, 11(3): 445±448.